Vicky Stinson, 65, defies a stage III pancreatic cancer prognosis with new drug daraxonrasib, extending normalcy. After 13 months, cancer returned, but she remains hopeful for emerging treatments like mRNA vaccines and tumor-treating fields.
Breakthrough Treatments Offer New Hope for Pancreatic Cancer
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →